Pharmacophoric Features of Drugs with Guanylurea Moiety: an Electronic Structure Analysis

Overview

Journal J Mol Model

Publisher Springer

Specialty Molecular Biology

Date 2013 Jan 18

PMID 23325568

Authors

Yoganjaneyulu Kasetti

Prasad V Bharatam

Affiliations

Soon will be listed here.

Abstract

Several therapeutically important compounds contain guanylurea (GU) moiety. The appropriate tautomeric state of these species has not been explored, preliminary studies indicated that the traditional representation of this class of compounds use a high energy tautomeric state. In this work, quantum chemical studies (HF, B3LYP, MP2, G2MP2 and CBS-Q methods) were performed on the medicinally important GU based drugs so as to identify their stable tautomeric state and to understand the pharmacophoric features of these drugs. Electronic structure studies suggested that GU-1 is the most stable and preferred isomer among the various ketone and enol isomers of the model GU. This study revealed that the general representation adopted in medicinal chemistry literature (GU-5) is about 10 kcal mol(-1) less stable than the energy minimum tautomeric state; and four other alternate structures are possible with energy less than that of the generally represented structure. Hence, it is advisable to consider the energy minimum tautomeric state (GU-1) in all future studies of GU derivatives. Further, the importance of the correct tautomeric representation was demonstrated using a comparative molecular docking analysis of WHR 1049 in α2A adrenergic receptor target.

References

Lee , Yang , PARR . Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density. Phys Rev B Condens Matter. 1988; 37(2):785-789. DOI: 10.1103/physrevb.37.785. View

Milletti F, Storchi L, Sforna G, Cross S, Cruciani G . Tautomer enumeration and stability prediction for virtual screening on large chemical databases. J Chem Inf Model. 2009; 49(1):68-75. DOI: 10.1021/ci800340j. View

Patel D, Bharatam P . Divalent N(I) compounds with two lone pairs on nitrogen. J Phys Chem A. 2011; 115(26):7645-55. DOI: 10.1021/jp111017u. View

Patel D, Bharatam P . Novel (+)N(<--L)2 species with two lone pairs on nitrogen: systems isoelectronic to carbodicarbenes. Chem Commun (Camb). 2009; (9):1064-6. DOI: 10.1039/b816595e. View

Kuhn B, Mohr P, Stahl M . Intramolecular hydrogen bonding in medicinal chemistry. J Med Chem. 2010; 53(6):2601-11. DOI: 10.1021/jm100087s. View

Eaker E, Bixler G, Mathias J . WHR 1049, a potent metabolite of lidamidine, has antidiarrheal and antimotility effects on the small intestine in rats. J Pharmacol Exp Ther. 1988; 246(2):786-9. View

Kasetti Y, Patel N, Sundriyal S, Bharatam P . Conformational polymorphism in sulfonylurea drugs: electronic structure analysis. J Phys Chem B. 2010; 114(35):11603-11. DOI: 10.1021/jp101327k. View

Manetti F, Castagnolo D, Raffi F, Zizzari A, Rajamaki S, DArezzo S . Synthesis of new linear guanidines and macrocyclic amidinourea derivatives endowed with high antifungal activity against Candida spp. and Aspergillus spp. J Med Chem. 2009; 52(23):7376-9. DOI: 10.1021/jm900760k. View

EMMETT J, Ganellin C, Graham M, Holloway F . Tautomerism of 4-methylhistamine--effect of the methyl substituent [proceedings]. Agents Actions. 1979; 9(1):27-8. DOI: 10.1007/BF02024092. View

10.

Bhatia S, Bagul C, Kasetti Y, Patel D, Bharatam P . Divalent N(I) character in 2-(thiazol-2-yl)guanidine: an electronic structure analysis. J Phys Chem A. 2012; 116(36):9071-9. DOI: 10.1021/jp304789u. View

11.

Bartolini B, Corniello C, Sella A, Somma F, Politi V . The enol tautomer of indole-3-pyruvic acid as a biological switch in stress responses. Adv Exp Med Biol. 2004; 527:601-8. DOI: 10.1007/978-1-4615-0135-0_69. View

12.

Mir G, Sperow J, Krebs J, Eash J, Rowles G, Yelnosky J . Mechanism of action studies of lidamidine hydrochloride (WHR-1142A), a novel antidiarrheal agent. Arzneimittelforschung. 1978; 28(8a):1454-61. View

13.

GREENHILL J, Lue P . Amidines and guanidines in medicinal chemistry. Prog Med Chem. 1993; 30:203-326. DOI: 10.1016/s0079-6468(08)70378-3. View

14.

Wojnarowska Z, Wlodarczyk P, Kaminski K, Grzybowska K, Hawelek L, Paluch M . On the kinetics of tautomerism in drugs: New application of broadband dielectric spectroscopy. J Chem Phys. 2010; 133(9):094507. DOI: 10.1063/1.3475688. View

15.

Mir G, Alioto R, Sperow J, Eash J, Krebs J, Yelnosky J . In vivo antimotility and antidiarrheal activity of lidamidine hydrochloride (WHR-1142A), a novel antidiarrheal agent. Comparison with diphenoxylate and loperamide. Arzneimittelforschung. 1978; 28(8a):1448-54. View

16.

Remko M, Swart M, Bickelhaupt F . Theoretical study of structure, pKa, lipophilicity, solubility, absorption, and polar surface area of some centrally acting antihypertensives. Bioorg Med Chem. 2005; 14(6):1715-28. DOI: 10.1016/j.bmc.2005.10.020. View

17.

Rarey M, Kramer B, Lengauer T, Klebe G . A fast flexible docking method using an incremental construction algorithm. J Mol Biol. 1996; 261(3):470-89. DOI: 10.1006/jmbi.1996.0477. View

18.

Wang C, Buck M, Fraser C . Site-directed mutagenesis of alpha 2A-adrenergic receptors: identification of amino acids involved in ligand binding and receptor activation by agonists. Mol Pharmacol. 1991; 40(2):168-79. View

19.

Patel D, Bharatam P . To bend or not to bend! The dilemma of allenes. J Org Chem. 2011; 76(8):2558-67. DOI: 10.1021/jo102432a. View

20.

Mehdi A, Adane L, Patel D, Bharatam P . Electronic structure and reactivity of guanylthiourea: a quantum chemical study. J Comput Chem. 2009; 31(6):1259-67. DOI: 10.1002/jcc.21412. View